Ask AI



Table of contents

Acute-on-chronic liver failure

What's new

Updated 2023 EASL guidelines for the evaluation and management of acute-on-chronic liver failure.



ACLF is a syndrome characterized by an acute decompensation of chronic liver disease, which is associated with organ failures and high short-term mortality.
The pathophysiology of ACLF involves a state of deregulated inflammation, with an initial cytokine burst presenting as systemic inflammatory response syndrome, progression to compensatory anti-inflammatory response syndrome, and associated immunoparalysis leading to sepsis and multi-organ failure.
The prevalence of ACLF in the US is estimated at 26.4% in hospitalized patients with decompensated cirrhosis.
Risk factors
Risk factors for ACLF include excessive alcohol consumption, chronic viral hepatitis, and sepsis. Recurrence of chronic viral hepatitis and ongoing alcohol abuse also contribute to the disease. However, in 40-50% of cases, no identifiable trigger can be found.
Disease course
Clinically, it presents with signs of liver failure such as jaundice, encephalopathy, coagulopathy, and ascites, with or without extrahepatic organ failure, including kidney, circulatory, and respiratory that can be complicated by sepsis. The clinical profile of ACLF is complex and can change over the course of hospital admission.
Prognosis and risk of recurrence
The prognosis is generally poor, with substantial short-term mortality.


Key sources

The following summarized guidelines for the evaluation and management of acute-on-chronic liver failure are prepared by our editorial team based on guidelines from the British Society for Haematology (BSH 2024), the European Association for the Study of the Liver (EASL 2023,2018), the Society of Critical Care Medicine (SCCM 2023,2020), and the American College of Gastroenterology (ACG 2022). ...
Show more

Screening and diagnosis

As per EASL 2023 guidelines:
Include both patients with and without prior decompensation in the definition of ACLF.
Use organ failures as included in the EASL-CLIF-C criteria for the diagnosis of ACLF.
Create free account

Classification and risk stratification

Prediction of ACLF: as per EASL 2023 guidelines, use the CLIF-C acute decompensation score sequentially to provide prognostic information regarding 90-day, 180-day, and 365-day mortality in patients without ACLF.
Show 3 more

More topics in this section

  • Severity assessment

Diagnostic investigations

Evaluation of precipitants: as per EASL 2023 guidelines, obtain systematic evaluation to identify the most common precipitants, including proven bacterial infection, alcohol-related hepatitis, gastrointestinal hemorrhage with hemodynamic instability, flare of HBV infection, HEV infection, recent use of a drug known to cause cerebral failure, and recent use of a drug known to cause kidney failure, in all patients admitted for ACLF or developing ACLF during hospital stay.
Show 3 more

More topics in this section

  • Medication review

  • Viscoelastic testing

  • Coagulation studies

  • Nutritional assessment

  • Evaluation for infection

Respiratory support

Supplemental oxygen
As per SCCM 2020 guidelines:
Provide supportive care with supplemental oxygen in the management of patients with hepatopulmonary syndrome, pending possible liver transplantation.
Consider using high-flow nasal cannula over noninvasive ventilation in hypoxic critically ill patients with ACLF.

More topics in this section

  • Mechanical ventilation

Medical management

General principles, setting of care: as per EASL 2023 guidelines, admit patients with ACLF requiring close monitoring or organ support to the ICU.
Show 4 more

More topics in this section

  • General principles (goals of care)

  • General principles (supportive care)

  • General principles (precautions)

  • Fluid resuscitation

  • Albumin

  • Vasopressors

  • Thromboprophylaxis

  • Antibiotic prophylaxis

  • G-CSF

  • Sedation

  • Management of variceal hemorrhage

  • Management of portopulmonary hypertension

  • Management of vascular complications

  • Management of infection

  • Management of SBP

  • Management of septic shock

  • Management of hepatic encephalopathy

  • Management of AKI

  • Management of beta-blockers

Inpatient care

Hemodynamic monitoring
As per SCCM 2020 guidelines:
Consider placing an arterial catheter for BP monitoring in patients with ACLF and shock.
Consider obtaining invasive hemodynamic monitoring to guide therapy in patients with ACLF and clinically impaired perfusion.

Nonpharmacologic interventions

Nutrition, route of administration
As per EASL 2023 guidelines:
Prefer oral intake whenever possible. Attempt enteral nutrition, ideally using a nasojejunal tube, if oral intake is not possible. Consider initiating parenteral nutrition if enteral nutrition is not tolerated.
Initiate oral nutrition as soon as possible in patients experiencing variceal bleeding/upper gastrointestinal bleeding. Recognize that enteral nutrition can be used safely.

More topics in this section

  • Nutrition (total calories)

  • Nutrition (proteins)

  • Nutrition (oral supplements)

  • Nutrition (fasting/refeeding)

Therapeutic procedures

Blood transfusion: as per ACG 2022 guidelines, avoid administering transfusions in the absence of bleeding or a planned procedure in patients with ACLF and altered coagulation parameters.

More topics in this section

  • Large-volume paracentesis

  • Pleurodesis

  • Extracorporeal liver support

Perioperative care

Periprocedural management: as per BSH 2024 guidelines, consider seeking specialist input for patients with ACLF undergoing an essential procedure. Consider administering fibrinogen, platelet, and other coagulation factor replacement on a case-by-case basis.

More topics in this section

  • Peritransplant management

Surgical interventions

Liver transplantation: as per EASL 2023 guidelines, consider obtaining an early assessment for liver transplantation in all patients with severe ACLF (ACLF-2 or -3).
Show 4 more

Specific circumstances

Patients with alcohol-associated hepatitis: as per EASL 2023 guidelines, do not use corticosteroids in patients with severe alcohol-related hepatitis and ACLF or uncontrolled bacterial infection.
Show 2 more

More topics in this section

  • Patients with HBV infection

  • Patients with AIH